Sporadic solitary aldosterone-and cortisol-co-secreting adenomas: Endocrine, histological and genetic findings in a subtype of primary aldosteronism

Hypertension Research

Volumn 33, Issue 5, 2010, Pages 467-472

  Willenberg, Holger S ^a   Späth, Martin ^a   Maser Gluth, Christiane ^b   Engers, Rainer ^a   Anlauf, Martin ^a   Dekomien, Gabriele ^c   Schott, Matthias ^a   Schinner, Sven ^a   Cupisti, Kenko ^a   Scherbaum, Werner A ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Adrenal; Aldosterone; Cortisol; Hypercortisolism; Primary aldosteronism

Indexed keywords

18 HYDROXYHYDROCORTISONE; ALDOSTERONE; ALDOSTERONE SYNTHASE; ANGIOTENSIN 1 RECEPTOR; CORTICOTROPIN; DEXAMETHASONE; FLUDROCORTISONE; HYDROCORTISONE; PRASTERONE SULFATE; SPIRONOLACTONE; STEROID 17ALPHA MONOOXYGENASE;

ADRENAL TUMOR; ADRENALECTOMY; ADULT; ARTICLE; CASE REPORT; CUSHING SYNDROME; DEPRESSION; ENDOCRINE FUNCTION TEST; EPISODIC VERTIGO; FEMALE; HUMAN; HYPERTENSION; HYPERTENSIVE CRISIS; HYPOKALEMIA; KIDNEY ARTERY STENOSIS; NOCTURIA; OBESITY; POSTMENOPAUSE; PRIMARY HYPERALDOSTERONISM; PROTEIN EXPRESSION; SKIN ATROPHY; THIRST; THROMBOCYTE COUNT; WEIGHT GAIN; WESTERN BLOTTING; XEROSTOMIA;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ALDOSTERONE; ALDOSTERONE SYNTHASE; BLOTTING, WESTERN; FEMALE; HUMANS; HYDROCORTISONE; HYPERALDOSTERONISM; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; STEROID 17-ALPHA-HYDROXYLASE; TREATMENT OUTCOME;

EID: 77951971879     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2010.18     Document Type: Article

References (53)

1. Gordon RD, Ziesak MD, Tunny TJ, Stowasser M, Klemm SA. Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers. Clin Exp Pharmacol Physiol 1993; 20: 296-298.
2. Fardella C, Mosso L, Gomez-Sanchez C, Cortés P, Soto J, Gómez L, Pinto M, Huete A, Oestreicher E, Foradori A, Montero J. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 2000; 85: 1863-1867.
3. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young Jr WF. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004; 89: 1045-1050.
4. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F, PAPY Study Investigators. A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients. J Am Coll Cardiol 2006; 48: 2293-2300.
5. Rayner B. Primary aldosteronism and aldosterone-associated hypertension. J Clin Pathol 2008; 61: 825-831.
6. Stowasser M. Update in primary aldosteronism. J Clin Endocrinol Metab 2009; 94: 3623-3630.
7. Komiya I, Koizumi Y, Kobayashi R, Kotani M, Yamada T, Maruyama Y. Concurrent hypersecretion of aldosterone and cortisol from the adrenal cortical adenoma. Am J Med 1979; 67: 516-518.
8. Guthrie GP, Kotchen TA. Hypertension and aldosterone overproduction without renin suppression in Cushing's syndrome from an adrenal adenoma. Am J Med 1979; 67: 524-528.
9. Tunny TJ, Klemm SA, Gordon RD. Some aldosterone-producing adrenal tumours also secrete cortisol, but present clinically as primary aldosteronism. Clin Exp Pharmacol Physiol 1990; 17: 167-171.
10. Hobma S, Hermus A, Smals A, Kloppenborg P. Concurrent hypercortisolism and hyperaldosteronism due to an adrenal adenoma. Klin Wochenschr 1990; 68: 981-983.
11. Nagae A, Murakami E, Hiwada K, Kubota O, Takada Y, Ohmori T. Primary aldosteronism with cortisol overproduction from bilateral multiple adrenal adenomas. Jpn J Med 1991; 30: 26-31.
12. Imai T, Seo H, Murata Y, Funahashi H, Satoh Y, Sasano H, Matsui N, Takagi H. Dexamethasone-nonsuppressible cortisol in two cases with aldosterone-producing adenoma. J Clin Endocrinol Metab 1991; 72: 575-581.
13. Baert D, Nobels F, Van Crombrugge P. Combined Conn's and Cushing's syndrome: an unusual presentation of adrenal adenoma. Acta Clin Belg 1995; 50: 310-313.
14. Allan CA, Kaltsas G, Perry L, Lowe DG, Reznek R, Carmichael D, Monson JP. Concurrent secretion of aldosterone and cortisol from an adrenal adenoma\value of MRI in diagnosis. Clin Endocrinol 2000; 53: 749-753.
15. Makino S, Oda S, Saka T, Yasukawa M, Komatsu F, Sasano H. A case of aldosterone-producing adrenocortical adenoma associated with preclinical Cushing's syndrome and hypersecretion of parathyroid hormone. Endocr J 2001; 48: 103-111.
16. Honda T, Nakamura T, Saito Y, Ohyama Y, Sumino H, Kurabayashi M. Combined primary aldosteronism and preclinical Cushing's syndrome: an unusual case presentation of adrenal adenoma. Hypertens Res 2001; 24: 723-726.
17. Yamakita N, Murai T, Miyamoto K, Matsunami H, Ikeda T, Sasano H, Mune T, Yasuda K. Variant of pre-clinical Cushing's syndrome: hypertension and hypokalemia associated with normoreninemic normoaldosteronism. Hypertens Res 2002; 25: 623-630.
18. Tanaka M, Izeki M, Miyazaki Y, Horigome M, Yoneda T, Tsuyuki S, Takami S, Aiba M. Combined primary aldosteronism and Cushing's syndrome due to a single adrenocortical adenoma complicated by Hashimoto's thyroiditis. Intern Med 2002; 41: 967-971.
19. Sugawara A, Takeuchi K, Suzuki T, Itoi K, Sasano H, Ito S. A case of aldosterone-producing adrenocortical adenoma associated with a probable post-operative adrenal crisis: histopathological analyses of the adrenal gland. Hypertens Res 2003; 26: 663-668.
20. Adachi J, Hirai Y, Terui K, Nakano T, Fukuda Y, Suda T, Sasano H. A report of 7 cases of adrenal tumors secreting both cortisol and aldosterone. Intern Med 2003; 42: 714-718.
21. Markou A, Tsigou K, Papadogias D, Kossyvakis K, Vamvakidis K, Kounadi T, Piaditis G. A unique case of a benign adrenocortical tumor with triple secretion of cortisol, androgens, and aldosterone: development of multiple sclerosis after surgical removal of the tumor. Hormones 2005; 4: 226-230.
22. Fujii H, Kamide K, Miyake O, Abe T, Nagai M, Nakahama H, Horio T, Takiuchi S, Okuyama A, Yutani C, Kawano Y. Primary aldosteronism combined with preclinical Cushing's syndrome in an elderly patient. Circ J 2005; 69: 1425-1427.
23. Okura T, Miyoshi K, Watanabe S, Kurata M, Irita J, Manabe S, Fukuoka T, Higaki J, Sasano H. Coexistence of three distinct adrenal tumors in the same adrenal gland in a patient with primary aldosteronism and preclinical Cushing's syndrome. Clin Exp Nephrol 2006; 10: 127-130.
24. Sasaki N, Iwase M, Arima H, Nohara S, Bandai S, Yao T, Fujii K, Iida M. Overt diabetes mellitus in a patient with combined primary aldosteronism and Cushing's syndrome. Intern Med 2006; 45: 1237-1242.
25. Saito T, Ikoma A, Saito T, Tamemoto H, Suminaga Y, Yamada S, Kawakami M, Suzuki T, Sasano H, Ishikawa SE. Possibly simultaneous primary aldosteronism and preclinical Cushing's syndrome in a patient with double adenomas of right adrenal gland. Endocr J 2007; 54: 287-293.
26. Suzuki J, Otsuka F, Inagaki K, Otani H, Miyoshi T, Terasaka T, Ogura T, Omori M, Nasu Y, Makino H. Primary aldosteronism caused by a unilateral adrenal adenoma accompanied by autonomous cortisol secretion. Hypertens Res 2007; 30: 367-373.
27. Tsunoda K, Abe K, Yamada M, Kato T, Yaoita H, Taguma Y, Goto Y, Ioridani N. A case of primary aldosteronism associated with renal artery stenosis and preclinical Cushing's syndrome. Hypertens Res 2008; 31: 1669-1675.
28. Oki K, Yamane K, Sakashita Y, Kamei N, Watanabe H, Toyota N, Shigeta M, Sasano H, Kohno N. Primary aldosteronism and hypercortisolism due to bilateral functioning adrenocortical adenomas. Clin Exp Nephrol 2008; 12: 382-387.
29. Rossi E, Foroni M, Regolisti G, Perazzoli F, Negro A, Santi R, Grasselli C, Galli P, Gardini G. Combined Conn's syndrome and subclinical hypercortisolism from an adrenal adenoma associated with homolateral renal carcinoma. Am J Hypertens 2008; 21: 1269-1272.
30. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young Jr WF, Montori VM. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008; 93: 3266-3281.
31. Haase M, Ansurudeen I, Paramonova I, Schinner S, Schott M, Papewalis C, Scherbaum WA, Willenberg HS. Evidence for the involvement of endothelial cell products in adrenal CITED2 expression. Cell Tissue Res 2009; 336: 337-343.
32. Vecsei P, Abdelhamid S, Mittelstadt GV, Lichtwald K, Haack D, Lewicka S. Aldosterone metabolites and possible aldosterone precursors in hypertension. J Steroid Biochem 1983; 19: 345-351.
33. Yokota K, Ogura T, Kishida M, Suzuki J, Otsuka F, Mimura Y, Oishi T, Hirata M, Tobe K, Makino H. Japanese family with glucocorticoid-remediable aldosteronism diagnosed by long-polymerase chain reaction. Hypertens Res 2001; 24: 589-594.
34. Stowasser M, Tunny TJ, Klemm SA, Gordon RD. Cortisol production by aldosterone-producing adenomas in vitro. Clin Exp Pharmacol Physiol 1993; 20: 292-295.
35. Gordon RD. Primary aldosteronism. J Endocrinol Invest 1995; 18: 495-511.
36. Stowasser M, Bachmann AW, Tunny TJ, Gordon RD. Production of 18-oxo-cortisol in subtypes of primary aldosteronism. Clin Exp Pharmacol Physiol 1996; 23: 591-593.
37. Sutherland DJ, Ruse JL, Laidlaw JC. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc J 1966; 95: 1109-1119.
38. New MI, Peterson RE. A new form of congenital adrenal hyperplasia. J Clin Endocrinol Metab 1967; 27: 300-305.
39. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldos-teronism and human hypertension. Nature 1992; 355: 262-265.
40. Pascoe L, Curnow KM, Slutsker L, Conello JMC, Speiser PW, New MI, White PC. Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Proc Natl Acad Sci USA 1992; 89: 8327-8331.
41. Mosso L, Gomez-Sanchez CE, Foecking MF, Fardella C. Serum 18-hydroxycortisol in primary aldosteronism, hypertension, and normotensives. Hypertension 2001; 38: 688-691.
42. Geller DS, Zhang J, Wisgerhof MV, Shackleton C, Kashgarian M, Lifton RP. A novel form of human mendelian hypertension featuring nonglucocorticoid- remediable aldosteron-ism. J Clin Endocrinol Metab 2008; 93: 3117-3123.
43. Willenberg HS, Schinner S, Ansurudeen I. New mechanisms to control aldosterone synthesis. Horm Metab Res 2008; 40: 435-441.
44. Naville D, Penhoat A, Durand P, Begeot M. Three steroidogenic factor-1 binding elements are required for constitutive and cAMP-regulated expression of the human adrenocorticotropin receptor gene. Biochem Biophys Res Commun 1999; 255: 28-33.
45. Sarkar D, Kambe F, Hayashi Y, Ohmori S, Funahashi H, Seo H. Involvement of AP-1 and steroidogenic factor (SF)-1 in the cAMP-dependent induction of human adrenocortico-tropic hormone receptor (ACTHR) promoter. Endocr J 2000; 47: 63-75.
46. Willenberg HS, Stratakis CA, Marx C, Ehrhart-Bornstein M, Chrousos GP, Bornstein SR. Aberrant interleukin-1 receptors in a cortisol-secreting adrenal adenoma causing Cushing's syndrome. N Engl J Med 1998; 339: 27-31.
47. Ganguly A. Cellular origin of aldosteronomas. Clin Investig 1992; 70: 392-395.
48. Schubert B, Fassnacht M, Beuschlein F, Zenkert S, Allolio B, Reincke M. Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms. Clin Endocrinol 2001; 54: 627-632.
49. Oda N, Takeda Y, Zhu A, Usukura M, Yoneda T, Takata H, Mabuchi HI. Pathophysio-logical roles of the adrenal renin-angiotensin system in patients with primary aldoster-onism. Hypertens Res 2006; 29: 9-14.
50. Mazzuco TL, Lampron A, Bourdeau I, Lacroix A. Aberrant hormone receptors in primary aldosteronism. Horm Metab Res 2010 (e-pub ahead of print; in press).
51. Suzuki H, Shibata H, Maruyama T, Ishimura Y, Saruta T. Significance of steroidogenic enzymes in the pathogenesis of hyperfunctioning and non-hyperfunctioning adrenal tumor. Steroids 1995; 60: 42-47.
52. Shigematsu K, Nishida N, Sakai H, Igawa T, Suzuki S, Kawai K, Takahara O. Primary aldosteronism with aldosterone-producing adenoma consisting of pure zona glomer-ulosa-type cells in a pregnant woman. Endocr Pathol 2009; 20: 66-72.
53. Nieman LK, Biller BMK, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The diagnosis of cushing's syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol 2008; 93: 1526-1540.